Journal ArticleOPEN ACCESS

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer

  • Hussain M
  • Mateo J
  • Fizazi K
  • et al.
New England Journal of Medicine (2020) 383(24) 2345-2357
DOI: 10.1056/nejmoa2022485
728Citations
Citations of this article
440Readers
Mendeley users who have this article in their library.

Abstract

Abstract Background We previously reported that olaparib led to significantly longer imaging-based progression-free survival than the physician’s choice of enzalutamide or abiraterone among men wit...

Cite

CITATION STYLE

APA

Hussain, M., Mateo, J., Fizazi, K., Saad, F., Shore, N., Sandhu, S., … de Bono, J. (2020). Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer. New England Journal of Medicine, 383(24), 2345–2357. https://doi.org/10.1056/nejmoa2022485

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free